Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#71 / 100 Total
AUBN - Auburn National Bancorp Inc. - Stock Price Chart
TickerAUBN [NASD]
CompanyAuburn National Bancorp Inc.
CountryUSA
IndustryBanks - Regional
Market Cap76.61MEPS (ttm)0.17
P/E126.37EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-30.30%
P/S2.27EPS next 5Y-
P/B1.02EPS Q/Q-9.89%
Dividend4.92%Sales Q/Q14.11%
Insider Own56.60%Inst Own7.56%
Insider Trans0.68%Inst Trans-8.35%
Short Float0.53%EarningsJul 23/b
Analyst Recom-Target Price-
Avg Volume5.71K52W Range16.48 - 25.25
Auburn National Bancorporation, Inc. is a bank holding company. It engages in the provision of banking services to commercial and retail customers. The firm operates through the following segments: Commercial and Industrial, Construction and Land Development, Commercial Real Estate, Residential Real Estate, and Consumer Installment. The Commercial and Industrial segment includes loans to finance business operations, equipment purchases, or other needs for small and medium-sized commercial customers. The Construction and Land Development segment is comprised of both loans and credit lines for the purpose of purchasing, carrying and developing land into commercial developments or residential subdivisions. The Commercial and Industrial segment provides loans disaggregated into three classes: owner occupied, multi-family and other. The Residential Real Estate segment is involved in consumer mortgage and investment property. The Consumer Installment segment encompasses loans to individuals both secured by personal property and unsecured. The company was founded in 1990 and is headquartered in Auburn, AL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HAM WILLIAM F JRDirectorOct 01 '24Buy23.38611,4264,679Oct 01 02:18 PM
O'DONNELL SHANNONSenior Vice PresidentOct 01 '24Buy23.34296771,422Oct 01 02:13 PM
HOUSEL DAVID EDirectorOct 01 '24Buy23.36551,2857,771Oct 01 02:06 PM
Barrett J TuttDirectorOct 01 '24Buy23.36781,8228,732Oct 01 01:55 PM
HOUSEL DAVID EDirectorAug 30 '24Buy19.171001,9177,716Sep 03 04:09 PM
BRID - Bridgford Foods Corp. - Stock Price Chart
TickerBRID [NASD]
CompanyBridgford Foods Corp.
CountryUSA
IndustryPackaged Foods
Market Cap81.90MEPS (ttm)-0.11
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-11.82%
P/S0.35EPS next 5Y-
P/B0.65EPS Q/Q-358.62%
Dividend-Sales Q/Q-9.09%
Insider Own81.66%Inst Own4.64%
Insider Trans0.03%Inst Trans-0.93%
Short Float0.31%Earnings-
Analyst Recom-Target Price-
Avg Volume15.92K52W Range7.77 - 14.69
Aug-23-24 04:11PM Bridgford: Fiscal Q3 Earnings Snapshot (Associated Press Finance) -7.28%
Jun-03-24 02:52PM BRID Stock Earnings: Bridgford Foods Reported Results for Q2 2024 (InvestorPlace)
May-31-24 05:17PM Bridgford: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
Mar-15-24 11:53AM BRID Stock Earnings: Bridgford Foods Reported Results for Q1 2024 (InvestorPlace)
Mar-08-24 04:51PM Bridgford: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
Dec-19-23 09:51AM BRID Stock Earnings: Bridgford Foods Reported Results for Q3 2023 (InvestorPlace)
Jun-22-23 09:00AM EnWave and Bridgford Foods Sign Commercial License Agreement to Produce Military Ration Components (GlobeNewswire)
Mar-06-23 06:08PM Bridgford: Fiscal Q1 Earnings Snapshot (AP Finance)
Nov-30-22 07:56AM Top 10 Donut Companies and Brands in the World (Insider Monkey)
Nov-02-22 01:50PM Bridgford Foods Corporation (Nasdaq BRID) Announces Changes in Principal Officers (GlobeNewswire)
Bridgford Foods Corp. engages in the manufacture, market, and distribution of frozen and snack food products. It operates through the Frozen Food Products and Snack Food Products segments. The Frozen Food Products segment manufactures and distributes food products, including biscuits, bread dough items, roll dough items, and sandwiches. The Snack Food Products segment distributes both products manufactured by the company and third parties. The company was founded by Hugh H. Bridgford in February 1932 and is headquartered in Dallas, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bridgford Brian E.V.P. ProductionOct 01 '24Buy9.103002,7303,011Oct 01 02:11 PM
Bridgford Brian E.V.P. ProductionSep 11 '24Buy8.715004,3552,711Sep 13 04:48 PM
Bridgford Allan Jr.ConsultantSep 11 '24Buy8.801,0008,80044,000Sep 13 02:29 PM
Bridgford Richard EugeneV.P. Ind. Relations & SafetySep 11 '24Buy8.601059032,700Sep 11 05:06 PM
Bridgford Richard EugeneV.P. Ind. Relations & SafetySep 09 '24Buy8.602001,7202,595Sep 10 12:43 PM
ENGN - enGene Holdings Inc - Stock Price Chart
TickerENGN [NASD]
CompanyenGene Holdings Inc
CountryCanada
IndustryBiotechnology
Market Cap295.83MEPS (ttm)-5.36
P/E-EPS this Y98.95%
Forward P/E-EPS next Y-11.95%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.28EPS Q/Q-544.47%
Dividend-Sales Q/Q-
Insider Own63.38%Inst Own35.78%
Insider Trans-0.15%Inst Trans11.13%
Short Float1.34%EarningsSep 10/a
Analyst Recom1.00Target Price30.17
Avg Volume193.76K52W Range4.42 - 47.17
enGene Holdings, Inc. is a clinical-stage biotechnology company, which engages in developing gene therapies. It is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs. The company was founded by Anthony T. Cheung on April 24, 2023 and is headquartered in Saint-Laurent, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cooper Ronald Harold WilfredChief Executive OfficerSep 27 '24Buy5.7010,00057,00010,000Oct 01 08:02 AM
Glickman Richard MDirectorMay 28 '24Option Exercise0.8912010724,675May 29 06:12 PM
FONDS DE SOLIDARITE DES TRAVAI10% OwnerApr 22 '24Sale15.0047,854717,8103,036,153Apr 22 05:22 PM
FONDS DE SOLIDARITE DES TRAVAI10% OwnerApr 18 '24Sale15.014,57568,6713,084,107Apr 22 05:22 PM
FONDS DE SOLIDARITE DES TRAVAI10% OwnerApr 19 '24Sale15.001001,5003,084,007Apr 22 05:22 PM
VRDN - Viridian Therapeutics Inc - Stock Price Chart
TickerVRDN [NASD, RUT]
CompanyViridian Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap1.78BEPS (ttm)-4.25
P/E-EPS this Y27.08%
Forward P/E-EPS next Y-8.00%
PEG-EPS past 5Y20.35%
P/S6124.60EPS next 5Y-
P/B4.51EPS Q/Q20.05%
Dividend-Sales Q/Q0.00%
Insider Own13.08%Inst Own82.42%
Insider Trans19.45%Inst Trans0.31%
Short Float15.76%EarningsAug 08/b
Analyst Recom1.12Target Price39.56
Avg Volume1.49M52W Range10.93 - 24.75
Viridian Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of proprietary RNA-targeted therapeutics. Its product candidates include Cobomarsen, which treats patients with certain cancers, including cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma, and Remlarsen and MRG-229, which are made for the treatment of patients with pathological fibrosis. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Beetham Thomas W.Chief Operating OfficerSep 27 '24Buy23.415,000117,0506,000Sep 30 07:12 PM
Mahoney Stephen F.President and CEOSep 27 '24Buy23.3321,400499,26221,400Sep 30 07:10 PM
Fairmount Funds Management LLCDirectorSep 13 '24Buy18.751,600,00030,000,0003,445,813Sep 17 09:00 PM
Fairmount Funds Management LLCDirectorJan 22 '24Buy21.00476,1909,999,9901,839,954Jan 24 06:44 PM
BLNK - Blink Charging Co - Stock Price Chart
TickerBLNK [NASD, RUT]
CompanyBlink Charging Co
CountryUSA
IndustryEngineering & Construction
Market Cap198.25MEPS (ttm)-2.33
P/E-EPS this Y79.81%
Forward P/E-EPS next Y44.41%
PEG-EPS past 5Y-19.80%
P/S1.26EPS next 5Y-
P/B0.71EPS Q/Q70.37%
Dividend-Sales Q/Q1.28%
Insider Own5.88%Inst Own35.93%
Insider Trans-0.14%Inst Trans28.26%
Short Float26.59%EarningsAug 07/a
Analyst Recom1.75Target Price4.25
Avg Volume4.70M52W Range1.53 - 4.66
Blink Charging Co. engages in the operation and provision of electric vehicles, charging equipment, and networked EV charging services. Its product line and services include the Blink EV charging network, charging equipment, also known as electric vehicle supply equipment, and EV charging services. The company was founded by Michael D. Farkas on October 3, 2006 and is headquartered in Bowie, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LEVINE JACKDirectorSep 26 '24Buy1.7020,00034,000175,718Sep 30 06:00 PM
Peterson Kristina A.DirectorSep 19 '24Sale1.8024,07743,3770Sep 23 06:00 PM
Peterson Kristina A.DirectorJun 25 '24Sale2.774,51012,5150Jun 27 05:00 PM
EP - Empire Petroleum Corporation - Stock Price Chart
TickerEP [AMEX, RUT]
CompanyEmpire Petroleum Corporation
CountryUSA
IndustryOil & Gas E&P
Market Cap170.80MEPS (ttm)-0.63
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-12.15%
P/S3.95EPS next 5Y-
P/B2.74EPS Q/Q-31.96%
Dividend-Sales Q/Q30.92%
Insider Own24.80%Inst Own40.01%
Insider Trans0.52%Inst Trans1.13%
Short Float5.62%Earnings-
Analyst Recom-Target Price-
Avg Volume45.99K52W Range4.06 - 10.99
Empire Petroleum Corp. engages in the exploration and development of oil and natural gas. The company possesses long-life, low operational cost, mature, producing assets with slow decline profiles in the Permian Basin, Bakken region and central Gulf Coast region, in the states of New Mexico, North Dakota, Montana, Louisiana, and Texas. Empire focuses on economical well rehabilitation, stimulation, field maintenance and management to generate low-risk cash flows that provides stability and growth for shareholders. The company was founded in August 1983 and is headquartered in Tulsa, OK.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mulacek Phil EDirectorSep 25 '24Buy4.981,3736,8384,706,493Sep 30 05:54 PM
Mulacek Phil EDirectorSep 30 '24Buy5.167413,8244,707,234Sep 30 05:54 PM
Mulacek Phil EDirectorJun 25 '24Buy5.2933,295176,1314,700,472Jul 01 07:12 AM
Mulacek Phil EDirectorJun 28 '24Buy5.394,64825,0534,705,120Jul 01 07:12 AM
Mulacek Phil EDirectorJun 28 '24Buy5.626003,372534,936Jul 01 07:12 AM
NAMS - NewAmsterdam Pharma Company NV - Stock Price Chart
TickerNAMS [NASD]
CompanyNewAmsterdam Pharma Company NV
CountryNetherlands
IndustryBiotechnology
Market Cap1.60BEPS (ttm)-
P/E-EPS this Y-10.79%
Forward P/E-EPS next Y27.03%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B4.12EPS Q/Q-627.95%
Dividend-Sales Q/Q-
Insider Own51.64%Inst Own37.66%
Insider Trans-0.07%Inst Trans-16.08%
Short Float0.97%EarningsAug 07/b
Analyst Recom1.20Target Price37.00
Avg Volume361.26K52W Range5.63 - 26.35
Oct-04-24 04:30PM NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Sep-06-24 04:32PM NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Aug-30-24 08:00AM NewAmsterdam Pharma to Participate in Upcoming Investor Conferences in September (GlobeNewswire)
Aug-07-24 08:00AM NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter Financial Results (GlobeNewswire)
Aug-02-24 04:01PM NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -6.35%
Jul-29-24 08:54AM NewAmsterdam Touts Cholesterol Drug Success, But Results Trail Analysts' Expectations (Investor's Business Daily) -8.54%
08:00AM NewAmsterdam Pharma Announces Positive Topline Data from Pivotal Phase 3 BROOKLYN Clinical Trial Evaluating Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia (GlobeNewswire)
Jul-26-24 04:01PM NewAmsterdam Pharma to Announce Topline Data from Pivotal Phase 3 BROOKLYN Clinical Trial Evaluating Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia on Monday, July 29, 2024 (GlobeNewswire)
Jul-18-24 08:00AM NewAmsterdam Pharma Announces Appointments of Mark C. McKenna and Wouter Joustra to its Board of Directors (GlobeNewswire)
Jul-08-24 08:00AM NewAmsterdam Pharma Completes Enrollment in Pivotal Phase 3 TANDEM Clinical Trial Evaluating Fixed-Dose Combination of Obicetrapib plus Ezetimibe in Patients with HeFH and/or ASCVD or ASCVD Risk Factors (GlobeNewswire)
NewAmsterdam Pharma Co. NV is a clinical-stage biopharmaceutical company, which engages in the development of oral, non-statin medicine for patients at high risk of cardiovascular disease with residual elevation of low-density lipoprotein cholesterol. Its lead product candidate, Obicetrapib, is a next-generation, oral, low-dose cholesteryl ester transfer protein inhibitor, which will be used to prevent major adverse cardiovascular events. The company was founded on June 10, 2022 and is headquartered in Naarden, the Netherlands.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kooij Louise FrederikaChief Accounting OfficerOct 01 '24Sale15.7245,000707,4000Oct 01 05:23 PM
Kooij Louise FrederikaOfficerOct 01 '24Proposed Sale17.2945,000778,050Oct 01 05:12 PM
Audet Juliette BerangereChief Business OfficerSep 26 '24Buy15.701,10417,3331,104Sep 30 05:22 PM
Davidson Michael H.Chief Executive OfficerAug 20 '24Buy16.275,00081,350209,784Aug 22 04:30 PM
Davidson Michael H.Chief Executive OfficerJun 20 '24Buy17.265,00086,308204,784Jun 24 08:30 AM
OTLK - Outlook Therapeutics Inc - Stock Price Chart
TickerOTLK [NASD, RUT]
CompanyOutlook Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap120.90MEPS (ttm)-10.75
P/E-EPS this Y3.42%
Forward P/E-EPS next Y50.97%
PEG-EPS past 5Y52.49%
P/S-EPS next 5Y-
P/B-EPS Q/Q45.02%
Dividend-Sales Q/Q-
Insider Own35.60%Inst Own35.99%
Insider Trans0.06%Inst Trans15.95%
Short Float16.21%EarningsAug 14/b
Analyst Recom1.14Target Price37.43
Avg Volume224.73K52W Range4.40 - 18.00
Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of ONS-5010/LYTENAVA. Its pipeline includes unmet patient needs, repackaged IV bevacizumab, and anti-VEGF. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Iselin, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KENYON LAWRENCE AChief Financial OfficerSep 26 '24Buy5.695,00028,4465,946Sep 30 04:53 PM
Haddadin Yezan MuntherDirectorMar 28 '24Buy11.821,88222,2425,049Mar 29 10:39 AM
Evanson JeffCHIEF COMMERCIAL OFFICERMar 07 '24Buy0.4262,48426,243808,459Mar 11 04:43 PM
BCOV - Brightcove Inc - Stock Price Chart
TickerBCOV [NASD]
CompanyBrightcove Inc
CountryUSA
IndustrySoftware - Application
Market Cap108.71MEPS (ttm)-0.20
P/E-EPS this Y-150.00%
Forward P/E-EPS next Y-20.00%
PEG-EPS past 5Y-6.25%
P/S0.54EPS next 5Y15.00%
P/B1.14EPS Q/Q18.99%
Dividend-Sales Q/Q-3.41%
Insider Own8.18%Inst Own73.15%
Insider Trans6.09%Inst Trans-10.72%
Short Float0.19%EarningsAug 07/a
Analyst Recom2.00Target Price3.88
Avg Volume184.27K52W Range1.55 - 3.18
Brightcove, Inc. engages in the provision of video cloud solutions. The firm enables its customers to publish and distribute video to Internet-connected devices. Its products include Brightcove Video Cloud, Brightcove Live, Brightcove Beacon, Brightcove Player, Zencoder, and Brightcove Audience Insights. The company was founded by Jeremy J. Allaire and Robert Mason in August 2004 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Edenbrook Capital, LLC10% OwnerSep 26 '24Buy2.0720,00041,4006,651,535Sep 30 04:50 PM
Edenbrook Capital, LLC10% OwnerSep 19 '24Buy2.002,9015,8026,631,535Sep 19 05:08 PM
Edenbrook Capital, LLC10% OwnerSep 18 '24Buy2.002,0964,1926,628,634Sep 19 05:08 PM
Edenbrook Capital, LLC10% OwnerSep 12 '24Buy2.005,00310,0066,626,538Sep 16 04:29 PM
Edenbrook Capital, LLC10% OwnerSep 06 '24Buy2.0411,60023,6746,616,305Sep 10 04:22 PM
MOFG - MidWestOne Financial Group Inc - Stock Price Chart
TickerMOFG [NASD, RUT]
CompanyMidWestOne Financial Group Inc
CountryUSA
IndustryBanks - Regional
Market Cap543.84MEPS (ttm)1.96
P/E13.76EPS this Y81.77%
Forward P/E9.22EPS next Y21.28%
PEG1.72EPS past 5Y-11.76%
P/S1.72EPS next 5Y8.00%
P/B0.78EPS Q/Q107.11%
Dividend3.59%Sales Q/Q34.40%
Insider Own9.52%Inst Own54.22%
Insider Trans0.80%Inst Trans0.61%
Short Float0.26%EarningsJul 25/a
Analyst Recom2.20Target Price31.10
Avg Volume55.68K52W Range19.19 - 30.51
MidWestOne Financial Group, Inc. is a financial holding company, focuses on delivering relationship-based business and personal banking products and services through its bank subsidiary, MidWestOne Bank. The Bank provides commercial loans, real estate loans, agricultural loans, credit card loans, and consumer loans. It also provides deposit products including demand and interest checking accounts, savings accounts, money market accounts, and time deposits. The Bank also provides products and services including treasury management, Zelle, online and mobile banking, debit cards, ATMs, and safe deposit boxes. It offers its products and services primarily through its full-service branch network, including 34 branches located throughout central and eastern Iowa, 13 branches located principally in the Minneapolis-St. Paul metropolitan area of Minnesota, seven branches in western Wisconsin, one branch in each of Naples and Fort Myers, Florida, and one branch in Denver, Colorado. MidWestOne Financial Group was founded in 1983 and is headquartered in Iowa City, IA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hayek Matthew JDirectorSep 30 '24Buy25.002,00050,00011,293Sep 30 04:40 PM
GREEFF DOUGLAS HDirectorSep 30 '24Buy25.004,000100,00013,891Sep 30 04:40 PM
Sims Gary LSVP & Chief Credit OfficerSep 30 '24Buy25.002,00050,00015,378Sep 30 04:40 PM
McCormick Tracy SDirectorSep 30 '24Buy25.002,00050,00092,565Sep 30 04:39 PM
ALBERT LARRY DDirectorSep 30 '24Buy25.0060015,00017,503Sep 30 04:39 PM
12345678910